ARTL

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Artelo Biosciences Inc

NASDAQ | ARTL

1.96

USD

$0.00

(

0.00%

)

At Close (As of Nov 11, 2025)

$4.21M

Market Cap

-

P/E Ratio

-18.93

EPS

$28.60

52 Week High

$1.66

52 Week Low

HEALTHCARE

Sector

ARTL Chart

Recent Chart
Price Action

ARTL Technicals

Tags:

ARTL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$10M
Selling General And Administrative $4.1M
Research And Development $6M
Operating Expenses $10M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$9.8M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.8M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$10M
Net Income -$9.8M

Revenue & Profitability

Earnings Performance

ARTL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $4.7M
Total Current Assets $2.6M
Cash And Cash Equivalents At Carrying Value $2.3M
Cash And Short Term Investments $2.3M
Inventory -
Current Net Receivables -
Total Non Current Assets $2.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2M
Intangible Assets Excluding Goodwill $2M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $219K
Other Non Current Assets -
Total Liabilities $1.8M
Total Current Liabilities $1.8M
Current Accounts Payable $1.7M
Deferred Revenue -
Current Debt -
Short Term Debt $35K
Total Non Current Liabilities $69K
Capital Lease Obligations $104K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $104K
Other Current Liabilities $58K
Other Non Current Liabilities -
Total Shareholder Equity $2.9M
Treasury Stock -
Retained Earnings -$50M
Common Stock $3K
Common Stock Shares Outstanding $3.2M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$8.4M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $7.8M
Cashflow From Financing $112K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.8M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$10M
Selling General And Administrative $4.1M
Research And Development $6M
Operating Expenses $10M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$9.8M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.8M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$10M
Net Income -$9.8M

ARTL News

ARTL Profile

Artelo Biosciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Artelo Biosciences, Inc. (ARTL) is a clinical-stage biopharmaceutical company headquartered in La Jolla, California, dedicated to pioneering therapies that target the endocannabinoid system to treat a range of medical conditions. The company's diverse pipeline is focused on enhancing the efficacy of cannabinoids, particularly in the areas of cancer, pain management, and appetite stimulation. With its commitment to scientific innovation and strict regulatory compliance, Artelo is well-positioned to meet significant unmet medical needs, representing a compelling investment opportunity in the burgeoning cannabinoid therapeutics market.

MSPR
+75.64%
$0.55
ASST
-1.98%
$1.48
ASBP
-24.64%
$0.11
NVDA
-2.95%
$193.16
PLUG
-1.17%
$2.53
PFE
+4.57%
$25.50
YDKG
-18.51%
$0.02
RIVN
+9.81%
$18.02
F
+1.10%
$13.30
ONDS
-1.36%
$5.80
INTC
+0.83%
$38.45
TSLA
+3.65%
$445.23
BYND
-9.32%
$1.21
CRWV
-16.42%
$88.26
VHAI
0.00%
$0.00
ACHR
+3.30%
$8.45
AXDX
-61.36%
$0.03
GRAB
-0.33%
$5.88
DNN
+3.52%
$2.64
WTO
-15.20%
$0.03
SOFI
+1.34%
$30.95
BITF
-5.86%
$3.37
RIG
+0.59%
$4.22
NIO
-1.04%
$6.64
RGTI
-5.07%
$31.40
ADAP
-15.14%
$0.05
DVLT
-3.55%
$1.63
PLTR
-1.36%
$190.96
MARA
-6.09%
$14.63
SNAP
+0.69%
$8.75
AAPL
+2.16%
$275.25
XPEV
+7.81%
$28.07
NBIS
-7.03%
$102.22
QBTS
-0.44%
$29.37
AMD
+4.47%
$243.98
WULF
+2.58%
$14.30
CHR
-11.25%
$0.05
AAL
-2.40%
$12.99
T
+1.47%
$25.19
ETHD
+7.38%
$4.43
BMNR
+2.28%
$41.15
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
CMG
-2.18%
$29.81
QS
-2.39%
$15.89
LFS
+576.78%
$11.37
BBD
+2.90%
$3.71
SRM
+53.27%
$10.30
NOK
-0.86%
$6.91
NVTS
-5.00%
$9.12
JOBY
+3.80%
$16.37
CIFR
-4.98%
$18.67
BTBT
-2.96%
$2.95
TURB
-12.44%
$2.18
SOUN
-6.73%
$13.44
CAN
-3.36%
$1.15
TLRY
-1.52%
$1.29
BURU
-6.40%
$0.25
IREN
-4.63%
$57.38
PBR
+3.49%
$13.46
LYFT
+1.93%
$24.18
KVUE
-0.29%
$16.72
HPE
-4.14%
$22.89
WLGS
-5.57%
$0.04
KLTR
+25.17%
$1.84
BTG
+0.61%
$4.11
IOVA
+11.81%
$2.65
BAC
+0.41%
$53.42
QUBT
-6.81%
$11.83
VCIG
+71.84%
$1.77
NGD
+2.31%
$7.29
RXRX
+4.43%
$4.71
HBAN
+0.06%
$15.82
CORZ
-10.21%
$17.32
PLTZ
+2.83%
$5.81
AGNC
+0.58%
$10.31
RF
+0.76%
$25.04
AMZN
+0.28%
$249.10
AFMD
-34.94%
$0.18
IONZ
+2.98%
$4.14
RKLB
+0.50%
$51.90
VALE
+0.32%
$12.34
STLA
+3.95%
$10.77
APLD
-9.12%
$28.57
MU
-4.81%
$241.11
VZ
-0.44%
$39.85
REAL
+38.09%
$15.48
GPUS
-3.42%
$0.34
RIOT
-6.81%
$16.14
HIMS
+0.04%
$41.05
CGC
-5.90%
$1.19
SMCI
-3.40%
$38.82
PLTD
+1.45%
$6.27
ABEV
+3.89%
$2.53
BTE
+2.70%
$2.66
PCG
+0.24%
$16.60
EOSE
-3.28%
$18.56
ORCL
-1.92%
$236.20
CLSK
-3.46%
$15.03
ITUB
+2.75%
$7.84
MSPR
+75.64%
$0.55
ASST
-1.98%
$1.48
ASBP
-24.64%
$0.11
NVDA
-2.95%
$193.16
PLUG
-1.17%
$2.53
PFE
+4.57%
$25.50
YDKG
-18.51%
$0.02
RIVN
+9.81%
$18.02
F
+1.10%
$13.30
ONDS
-1.36%
$5.80
INTC
+0.83%
$38.45
TSLA
+3.65%
$445.23
BYND
-9.32%
$1.21
CRWV
-16.42%
$88.26
VHAI
0.00%
$0.00
ACHR
+3.30%
$8.45
AXDX
-61.36%
$0.03
GRAB
-0.33%
$5.88
DNN
+3.52%
$2.64
WTO
-15.20%
$0.03
SOFI
+1.34%
$30.95
BITF
-5.86%
$3.37
RIG
+0.59%
$4.22
NIO
-1.04%
$6.64
RGTI
-5.07%
$31.40
ADAP
-15.14%
$0.05
DVLT
-3.55%
$1.63
PLTR
-1.36%
$190.96
MARA
-6.09%
$14.63
SNAP
+0.69%
$8.75
AAPL
+2.16%
$275.25
XPEV
+7.81%
$28.07
NBIS
-7.03%
$102.22
QBTS
-0.44%
$29.37
AMD
+4.47%
$243.98
WULF
+2.58%
$14.30
CHR
-11.25%
$0.05
AAL
-2.40%
$12.99
T
+1.47%
$25.19
ETHD
+7.38%
$4.43
BMNR
+2.28%
$41.15
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
CMG
-2.18%
$29.81
QS
-2.39%
$15.89
LFS
+576.78%
$11.37
BBD
+2.90%
$3.71
SRM
+53.27%
$10.30
NOK
-0.86%
$6.91
NVTS
-5.00%
$9.12
JOBY
+3.80%
$16.37
CIFR
-4.98%
$18.67
BTBT
-2.96%
$2.95
TURB
-12.44%
$2.18
SOUN
-6.73%
$13.44
CAN
-3.36%
$1.15
TLRY
-1.52%
$1.29
BURU
-6.40%
$0.25
IREN
-4.63%
$57.38
PBR
+3.49%
$13.46
LYFT
+1.93%
$24.18
KVUE
-0.29%
$16.72
HPE
-4.14%
$22.89
WLGS
-5.57%
$0.04
KLTR
+25.17%
$1.84
BTG
+0.61%
$4.11
IOVA
+11.81%
$2.65
BAC
+0.41%
$53.42
QUBT
-6.81%
$11.83
VCIG
+71.84%
$1.77
NGD
+2.31%
$7.29
RXRX
+4.43%
$4.71
HBAN
+0.06%
$15.82
CORZ
-10.21%
$17.32
PLTZ
+2.83%
$5.81
AGNC
+0.58%
$10.31
RF
+0.76%
$25.04
AMZN
+0.28%
$249.10
AFMD
-34.94%
$0.18
IONZ
+2.98%
$4.14
RKLB
+0.50%
$51.90
VALE
+0.32%
$12.34
STLA
+3.95%
$10.77
APLD
-9.12%
$28.57
MU
-4.81%
$241.11
VZ
-0.44%
$39.85
REAL
+38.09%
$15.48
GPUS
-3.42%
$0.34
RIOT
-6.81%
$16.14
HIMS
+0.04%
$41.05
CGC
-5.90%
$1.19
SMCI
-3.40%
$38.82
PLTD
+1.45%
$6.27
ABEV
+3.89%
$2.53
BTE
+2.70%
$2.66
PCG
+0.24%
$16.60
EOSE
-3.28%
$18.56
ORCL
-1.92%
$236.20
CLSK
-3.46%
$15.03
ITUB
+2.75%
$7.84
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.